GlobeNewswire

Ascom announces visionary platform for data-driven era of healthcare

Del

Ascom Holding AG / Ascom announces visionary platform for data-driven era of healthcare . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

The Ascom Healthcare Platform bridges information gaps to optimize digital workflows and meet the demands of clinical care

 

BAAR, Switzerland, March 05, 2018 (GLOBE NEWSWIRE) -- Ascom (SWX:ASCN.SW), a global solutions provider focused on healthcare ICT and mobile workflows, announces today in Las Vegas at HIMSS, Booth #4212, a new approach to delivering optimized digital clinical information flows with the Ascom Healthcare Platform. Delivering integrated and orchestrated clinical workflow solutions, the Ascom Healthcare Platform closes digital information gaps between devices, hospital systems and clinical care teams to extend the reach of critical information across points of care and enable informed, timely clinical decisions.

In today's clinical environments data is everywhere, but timely access to contextually relevant, digital information is still a challenge. Take an ICU patient, for example. In a single day, one ICU patient can generate up to 2,000 data points [1]. But data is just the starting point, clinicians need actionable insight for responsive patient care.

"The Ascom Healthcare Platform addresses the complexity of clinical care. Designed as an open and technology agnostic solution, the Platform takes a multi-dimensional approach to clinical workflows and digital information flows. By creating interoperability between existing medical devices, healthcare information systems and care management solutions, clinical care information becomes more insightful, accessible and actionable. And the benefits are tangible, including fewer instances of miscommunication, preventing double documentation errors, improving patient response time and increasing time available for patient care," comments Francis Schmeer, Ascom EVP Marketing & Business Development.

The Ascom Healthcare Platform is a distinct approach to delivering workflow digitization, workflow optimization as well as analytics and smart data.

  • Consulting teams work with hospitals to provide customized, interoperable, modular and scalable solutions from design, to implementation, integration and support.
  • Workflow Orchestration solutions streamline, filter and prioritize alerts and task notifications while extending the flow of information to mobile clinical care teams for more responsive and informed care communication and collaboration.
  • Analytics and smart data applications add and enable delivery of structure and clinical context to information, helping clinicians and care teams coordinate care to address patient needs. 

Together with Ascom's solution leadership in clinical orchestration software and applications from Digistat and Unite; Patient Response and Workflow Systems from Telligence and Mobility from the Myco smart device portfolio, the Ascom Healthcare Platform enables optimized clinical workflows from simple to complex. Across general wards, operating rooms and ICUs, Ascom enables care team coordination and collaboration; bedside vital signs registration; early warning scores, ICU central monitoring; medical asset management; operating room patient management systems and more. 

"The Ascom Healthcare Platform is the realization of a powerful vision, where digital clinical information is connected, optimized and accessible to clinicians, from the point of care to anywhere. Because the challenges around clinical data are vast and complex, we set out to bring together mobile clinical workflow technology and solutions to create a dynamic proposition that is both powerful and flexible. As we continue to innovate, the platform expands upon our market leadership in mobile workflows by bridging gaps and unlocking the full value of digital clinical information across points of care from general wards to operating rooms and Intensive Care Units and across care teams, when and where they need it most," says Holger Cordes, CEO of Ascom.

ABOUT ASCOM

Ascom is a global solutions provider focused on healthcare ICT and mobile workflow solutions. The vision of Ascom is to close digital information gaps allowing for the best possible decisions - anytime and anywhere. Ascom's mission is to provide mission-critical, real-time solutions for highly mobile, ad hoc, and time-sensitive environments. Ascom uses its unique product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide truly smooth, complete and efficient workflows for healthcare as well as for industry and retail sectors.

Ascom is headquartered in Baar (Switzerland), has operating businesses in 18 countries and employs around 1,300 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.

Multiple products from Ascom and third parties support the features and functions described herein. All Ascom solutions may not be available in specific countries.

[1] McFarling, Usha Lee. Raising an alarm, doctors fight to yank hospital ICUs into the modern era. Stat, 7 September 2016.

Ascom Group Media Office, Daniel Lack, Legal & Communications/IR

+41 41 544 78 10, daniel.lack@ascom.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ascom Holding AG via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Bombardier to supply a further 20 FLEXITY trams to Karlsruhe17.12.2018 10:00Pressemelding

Albtal-Verkehrs-Gesellschaft expands its fleet to 62 trams The dual-system vehicles operate on both the tram network and regional railway network BERLIN, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Global mobility solution provider Bombardier Transportation received a call-off order from Albtal-Verkehrs-Gesellschaft mbH (AVG), the transport company of the Alb valley region in southwest Germany, for the delivery of 20 further dual-system BOMBARDIER FLEXITY trams. This third order is based on a framework agreement for a total of 75 vehicles from 2009. The order is valued at approximately 87 million euro ($98 million US). The vehicles will be delivered between May 2020 and March 2021. "Striving to provide attractive local transport services, we have decided to order 20 additional dual-system vehicles from Bombardier Transportation. This will allow us to purposefully enlarge our vehicle fleet offering high-quality standards to our passengers," said Dr. Alexander Pischon, CEO of Albtal-Verkehrs-Gesel

DalCor Announces Completion of Patient Enrollment in dal-GenE, the First Phase 3 Precision Medicine Cardiovascular Outcomes Trial in Coronary Heart Disease17.12.2018 09:00Pressemelding

LONDON and MONTREAL, Dec. 17, 2018 (GLOBE NEWSWIRE) -- DalCor today announced the completion of patient enrollment in the dal-GenE study, the first Phase 3 precision medicine cardiovascular outcomes trial in coronary heart disease. The dal-GenE study is evaluating the efficacy of the CETP inhibitor dalcetrapib to reduce clinical cardiovascular events in patients with the AA ADCY9 genotype who have had a recent acute coronary syndrome (ACS). The study has enrolled over 6,000 patients and is being conducted in 680 sites in 32 countries. “The accelerated enrollment of patients in the dal-GenE study reflects the scientific enthusiasm and commitment among the medical community to bring the right medicine to the right patient,” said Dr. Jean-Claude Tardif from the Montreal Heart Institute. “ADCY9 genetic testing to identify the appropriate patients for treatment with dalcetrapib has the potential to provide a genetically targeted therapy to improve clinical outcomes. This approach could pave

Compuware Announces Day One Support for IBM CICS Transaction Server for z/OS V5.514.12.2018 18:02Pressemelding

DETROIT, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Compuware Corporation, the world’s leading mainframe-dedicated software company, is pleased to announce Day One support for IBM CICS Transaction Server (TS) for z/OS V5.5. Compuware worked in collaboration with IBM to ensure that its solutions—including Abend-AID, File-AID, Strobe, Topaz and Xpediter—work seamlessly for z/OS customers installing or upgrading to this newest version of CICS TS. New capabilities within CICS TS V5.5 include support for JavaScript Node.js applications; an enhanced CICS Explorer; as well as advancements in systems management and enhanced security. “Compuware has an extensive history of ensuring our products work seamlessly with IBM releases and the release of CICS Transaction Server V5.5 is no exception,” said Sam Knutson, Vice President of Product Management for Compuware. “Our solutions excel at helping enterprises include the mainframe in their cross-platform Agile DevOps practices and processes so they can succe

SoftServe Achieves Machine Learning Specialization in Google Cloud Partner Program14.12.2018 13:00Pressemelding

Google Cloud recognizes SoftServe’s technical proficiency and proven success AUSTIN, Texas, Dec. 14, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital authority and consulting company, announces it achieved the Machine Learning Partner Specialization in the Google Cloud Premier Partner Program. The Partner Specialization affirms SoftServe’s expertise and success building customer solutions in the machine learning field using Google Cloud Platform (GCP) technology. The Google Cloud Partner Specialization Program is designed to provide Google Cloud customers with qualified partners that demonstrate technical proficiency in the specialized solution and service areas. Specifically, the Machine Learning Specialization demonstrates SoftServe’s expertise in data exploration, preprocessing, model training, model evaluation, model deployment, online prediction, and Google Cloud’s pre-trained machine learning APIs. “We teach machines to learn, read, see and understand business data, and make

Minerals Technologies Announces Price Increases for Specialty Minerals Products in Europe14.12.2018 00:01Pressemelding

NEW YORK, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Specialty Minerals Inc. (“SMI”), a subsidiary of Minerals Technologies Inc., announced today that effective February 1, 2019, it will increase prices by up to 10% for all coated ultrafine precipitated calcium carbonate (PCC) from SMI’s Lifford Specialty PCC facility in Birmingham, UK, subject to individual customer contracts and market provisions. The price increases reflect increased market demand for higher performance materials, as well as significant inflation in input, raw material and logistics costs. About Minerals Technologies Inc. New York-based Minerals Technologies Inc. (MTI) is a resource- and technology-based growth company that develops, produces and markets worldwide a broad range of specialty mineral, mineral-based and synthetic mineral products and related systems and services. MTI serves the paper, foundry, steel, construction, environmental, energy, polymer and consumer products industries. The Company reported sales of $1.

Synthesio to Bring Proven Ipsos Data Science to Artificial Intelligence13.12.2018 17:03Pressemelding

Synthesio's Next-Generation Social Media Intelligence to Raise Unseen Insights to the Surface, Faster NEW YORK, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Synthesio, an Ipsos company, and also the leading Social Media Intelligence Suite, today announced the plans for its next-generation Artificial Intelligence (AI) engine. The project will combine Synthesio’s AI technology with Ipsos’ data science. The combination will power upcoming Synthesio capabilities to help users find insights faster, remove guesswork, and make informed business decisions across a variety of use cases. “Our goal has always been to provide customers with meaningful data, visualized so that they can make strategic business decisions,” explained Loic Moisand, CEO & Founder of Synthesio. “The less guesswork that a company has to make, and the less time that it takes users to find meaningful insights, the more time for data-backed business decisions. We are really pleased that we can leverage the data science capabilities dev